Zhu, W., Zhu, D., Lu, S., Wang, T., Wang, J., Jiang, B., . . . Liu, P. (2012). miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Medical oncology (Northwood, London, England), 29(1), 384-391. https://doi.org/10.1007/s12032-010-9797-4
Chicago Style (17th ed.) CitationZhu, Wei, DanXia Zhu, Shiqiang Lu, Tongshan Wang, Jian Wang, Binghua Jiang, Yongqian Shu, and Ping Liu. "MiR-497 Modulates Multidrug Resistance of Human Cancer Cell Lines by Targeting BCL2." Medical Oncology (Northwood, London, England) 29, no. 1 (2012): 384-391. https://doi.org/10.1007/s12032-010-9797-4.
MLA (9th ed.) CitationZhu, Wei, et al. "MiR-497 Modulates Multidrug Resistance of Human Cancer Cell Lines by Targeting BCL2." Medical Oncology (Northwood, London, England), vol. 29, no. 1, 2012, pp. 384-391, https://doi.org/10.1007/s12032-010-9797-4.